Warfarin Use among Ambulatory Patients with Nonvalvular Atrial Fibrillation: The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study
Article Abstract:
Many patients with atrial fibrillation who might benefit from warfarin treatment are not receiving it. Atrial fibrillation is a very rapid beating of the upper part of the heart. This can cause blood clots to form and travel to the brain, causing a stroke. Consequently, many patients take warfarin, and anticoagulant drug. However, in a study of 13,428 patients with atrial fibrillation, only 60% of the patients who would benefit from warfarin treatment actually received it. Patients younger than 55 and those older than 85 were less likely to receive warfarin.
Publication Name: Annals of Internal Medicine
Subject: Health
ISSN: 0003-4819
Year: 1999
User Contributions:
Comment about this article or add new information about this topic:
Oral propafenone to convert recent-onset atrial fibrillation in patients with and without underlying heart disease: a randomized, controlled trial
Article Abstract:
Propafenone appears to be a safe and effective treatment for recent onset atrial fibrillation. Researchers randomly assigned 240 patients with atrial fibrillation lasting a week or less to either oral propafenone or placebo. Three hours later, 45% of propafenone recipients had returned to a normal heart beat compared with 18% of the control group. By 8 hours, 76% of propafenone recipients versus 37% of the control group had returned to a normal heart beat. Propafenone caused only minor and transient adverse effects on heart beat or blood pressure.
Publication Name: Annals of Internal Medicine
Subject: Health
ISSN: 0003-4819
Year: 1997
User Contributions:
Comment about this article or add new information about this topic:
Management of newly detected atrial fibrillation: recommendations from the American College of Physicians and the American Academy of Family Physicians
Article Abstract:
Drugs that slow the heart and anticoagulants are the best treatments for atrial fibrillation, according to an extensive literature analysis by the American Academy of Family Physicians and the American College of Physicians. The most effective drugs to slow the heart are atenolol, metoprolol, diltiazem, and verapamil. Atrial fibrillation occurs when the upper part of the heart begins beating too fast.
Publication Name: Annals of Internal Medicine
Subject: Health
ISSN: 0003-4819
Year: 2003
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Evaluation of patients with abnormal uterine bleeding. Screening and diagnosis of coagulation disorders. A prospective study of transvaginal hydrosonography in the evaluation of abnormal uterine bleeding
- Abstracts: New treatments for Chlamydia trachomatis. Is tubal ligation a risk factor for low bone density and increased risk of fracture?
- Abstracts: Subcutaneous nodules in a patient with polyarthritis. Epidemiology of adult Still's disease: estimate of the incidence by a retrospective study in west France
- Abstracts: Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension: a randomized, double-blind multicenter study
- Abstracts: Controlling interests. Aids to helps district nurses boost patient nutrition and wound care. Early closing days: combination drug therapies have proved so effective at controlling HIV that AIDS wards are closing